Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodar

P. M. Fracasso, K. A. Blum, M. K. Ma, B. R. Tan, L. P. Wright, S. A. Goodner, C. L. Fears, W. Hou, M. A. Arquette, J. Picus, A. Denes, J. E. Mortimer, L. Ratner, S. P. Ivy, H. L. McLeod

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Fingerprint Dive into the research topics of 'Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodar'. Together they form a unique fingerprint.

Medicine & Life Sciences